Company / Return on Equity (ROE)
Korro Bio, Inc. Return on Equity (ROE) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-52.1%
FY2025
5-year range
-64.7% / -11.2%
FY2021-FY2025
Trend
-9.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Korro Bio, Inc. reports negative total equity of -52.1% in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-52.1% in FY2025 with a 5-year CAGR of -40.9%.
Improved from -64.7% to -52.1% over the past 3 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- +12.6pp
- 5-Year Change
- -40.9pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on equity (roe) decreased 9.1% year-over-year.
- Peak return on equity (roe) was recorded in FY2020.
- Lowest return on equity (roe) in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.49 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -52.1% | -9.1% |
| FY2024 | -47.8% | +26.2% |
| FY2022 | -64.7% | -370.1% |
| FY2021 | -13.8% | -22.9% |
| FY2020 | -11.2% | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026